Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CERTEV (Center of Expertise and Research in Inhaled Therapeutics) is a specialized research and service platform based in Tours, France, dedicated to the development and optimization of inhaled drug delivery systems. Affiliated with the University of Tours and INSERM, the center operates as a high-level Contract Research Organization (CRO) for the global pharmaceutical and biotechnology industries. CERTEV provides a comprehensive suite of services, including aerosol characterization, device performance testing, in vitro lung deposition modeling, and preclinical evaluation of inhaled formulations. The center is a key component of the Aerosol Valley cluster, supporting the development of treatments for respiratory conditions such as asthma, COPD, and cystic fibrosis, as well as innovative pulmonary delivery methods for vaccines and systemic therapies. Its expertise bridges the gap between academic research and industrial application, facilitating the transition of inhaled candidates from the lab to clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CERTEV.